newsfilter
← Latest News
Business Wire·

Guardant Health to Appeal Federal District Court Judgment

GH
  • Guardant Health announced it will appeal the final U.S. District Court judgment regarding intellectual property claims by TwinStrand Biosciences & University of Washington.
  • Execution of the final judgment & collection of potential royalties are stayed pending the outcome of the appeal.
  • The court order specifically excludes current versions of Guardant Reveal & Shield products from the royalty scope as they differ from products existing during the 2023 trial.
  • Guardant validated design improvements to Guardant360 & related services that further exclude them from potential ongoing royalties.
  • The company maintains it did not infringe the asserted patents & notes that both TwinStrand patents have been preliminarily invalidated in ongoing U.S. Patent and Trademark Office challenges.
  • Guardant is simultaneously pursuing separate appeals before the U.S. Court of Appeals for the Federal Circuit.